Stockscreener 앱 받기
295.54
0.99%
-2.96
Ligand Pharmaceuticals Inc 주식(LGND)의 최신 뉴스
Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo! Finance Canada
Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo! Finance Canada
Ligand Pharma CLO Andrew Reardon sells $1.52 million in stock By Investing.com - Investing.com South Africa
Ligand Pharma CLO Andrew Reardon sells $1.52 million in stock - Investing.com
Form 4 Ligand Pharmaceuticals Incorporated For: 11 October By Investing.com - Investing.com Canada
Ligand Pharmaceuticals Incorpor (LGND) Stock forecasts - Yahoo Finance UK
Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo Finance
Full Transcript: Ligand Pharmaceuticals Q2 2026 Earnings Call - Benzinga
Full Transcript: Ligand Pharmaceuticals Q2 2026 Earnings Call - Benzinga
Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo! Finance Canada
Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo Finance
Ligand Pharmaceuticals (LGND) Stock May Be 27% Undervalued After A New Royalty Deal - Yahoo Finance
Is Ligand Pharmaceuticals (LGND) Below Fair Value As It Funds AvenCell? - Yahoo Finance
Is Ligand Pharmaceuticals (LGND) Using AvenCell CAR-T Royalties To Redefine Its Cash-Flow Playbook? - Yahoo Finance
Form 4 Ligand Pharmaceuticals Incorporated For: 28 September By Investing.com - Investing.com Nigeria
Ligand (LGND)-AvenCell Deal: Most of the Funding Is Tied to Milestones - Yahoo Finance
Barclays Initiates Outperform on Ligand Pharmaceuticals (LGND) w - GuruFocus
Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation - TradingView
Barclays initiates Ligand Pharma stock with overweight rating - Investing.com
Barclays Initiates Ligand Pharmaceuticals at Overweight With $345 Price Target - Yahoo Finance
US53220KAJ7 Bond Profile: Coupon and Redemption - TradingView
Ligand Pharmaceuticals Invests Up to $47 Million in AvenCell - Yahoo Finance
Ligand and AvenCell Therapeutics Enter Financing Agreement - GlobeNewswire
Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo Finance
McDermott Will & Schulte advises Ligand Pharmaceuticals in $23 million acquisition of royalty and milestone interest in Santen’s Ryjunea® - McDermott Will & Schulte
Ligand Pharmaceuticals Acquires Ryjunea Royalty Interest for $23 Million - Yahoo Finance
Sydnexis Announces Royalty Agreement with Ligand for Ryjunea® - Yahoo Finance
Ligand Pharmaceuticals: The Multiple Is The Whole Bet; Hold - Seeking Alpha
A Ligand (NASDAQ: LGND) director is planning a stock sale; the filing shows how big - Stock Titan
Ligand Pharmaceuticals CLO Reardon sells $1.43m in stock By Investing.com - Investing.com Australia
Ligand Pharmaceuticals CLO Reardon sells $1.43m in stock By Investing.com - Investing.com Nigeria
Ligand Pharmaceuticals CLO Reardon sells $1.43m in stock By Investing.com - Investing.com Australia
Ligand Pharmaceuticals CLO Reardon sells $1.43m in stock By Investing.com - Investing.com Canada
Ligand Pharmaceuticals (LGND) Rides Royalty Growth Hopes, Is The Stock Still Undervalued? - simplywall.st
Ligand Pharmaceuticals CLO Reardon sells $1.43m in stock By Investing.com - Investing.com South Africa
Ligand Pharmaceuticals CLO Reardon sells $1.43m in stock By Investing.com - Investing.com UK
Ligand Pharmaceuticals Incorporated (LGND) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
ETFs Investing in Ligand Pharmaceuticals Incorporated Stocks - TradingView
Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book - Yahoo Finance
Ligand (NASDAQ: LGND) insider to sell 15,000 shares after plan trades - Stock Titan
XOMA Royalty Reports $41.2M First-Half Net Loss on Trial Failures - Minichart
If You Invested $100 In Ligand Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today - Benzinga
A cash-heavy royalty arm at Ligand (NASDAQ: LGND) is loss-making - Stock Titan
Price to earnings forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView
Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – OTC:LGNZZ - TradingView
Ligand Pharmaceuticals at Midwest IDEAS: royalty model gains scale By Investing.com - Investing.com Canada
Ligand to Participate in September Investor Conferences - marketscreener.com
Ligand executives will meet investors at three September events - Stock Titan
Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital - Yahoo Finance
Ligand (LGND) Snapshot: Ends Down by 2.13% at $280.18 for the Current Session; Price Setup: the Supplied Trading Band Runs From $266.17 to $294.19 at the CloseEarnings Breakout Stocks - vinanet.vn
2.05%
자본화:
|
볼륨(24시간):